TTOO - T2 Biosystems stock up 19% on earnings beat 2022 outlook

Shares of T2 Biosystems (NASDAQ:TTOO) are up 19% in post-market trading after reporting Q4 2021 earnings results that beat on the top and bottom lines. Also, fiscal year 2022 revenue guidance range it provided included the Street consensus. Revenue declined ~10% to ~$7M compared to the prior-year period . Net loss widened ~23% to ~$12.1M. Basic and diluted net loss per shared remained the same at -$0.07. Total costs and expenses increased ~7% to ~$17.3M. Read why Seeking Alpha contributor Edmund Ingham considers T2 Biosystems a hold.

For further details see:

T2 Biosystems stock up 19% on earnings beat, 2022 outlook